These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 6190027)

  • 41. [Clinical evaluations of antithrombin III and alpha 2-plasmin inhibitor assay method with chromogenic substrates (S-2238, S-2251 (author's transl)].
    Fukuda C; Iijima K; Nakamura K
    Rinsho Byori; 1981 Feb; 29(2):179-82. PubMed ID: 6453246
    [No Abstract]   [Full Text] [Related]  

  • 42. The effects of aprotinin on hemostatic function during cardiac surgery.
    Marx G; Pokar H; Reuter H; Doering V; Tilsner V
    J Cardiothorac Vasc Anesth; 1991 Oct; 5(5):467-74. PubMed ID: 1718476
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Assay of factor XII in human plasma using prekallikrein or the chromogenic peptide S-2222 as substrates--significance of the functional state of plasma kallikrein.
    Hoem NO; Johannesen S; Briseid K
    Thromb Res; 1989 May; 54(3):197-205. PubMed ID: 2787541
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Description and evaluation of a new chromogenic substrate assay kit for the determination of prekallikrein in human plasma.
    Friberger P; Gallimore MJ
    Adv Exp Med Biol; 1986; 198 Pt B():543-8. PubMed ID: 3643742
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Septic shock in the rat: activation of plasma proteolytic systems and effects of a kallikrein inhibitor/bradykinin antagonist (S-2441).
    Högström H; Claeson G; Larsson-Backström C; Lundberg D; Wenngren E; Haglund U
    Acta Chir Scand; 1987 Mar; 153(3):161-4. PubMed ID: 3300117
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differences in prekallikrein and high molecular weight kininogen levels in two strains of Brown Norway rat (Kitasato strain and Katholiek strain).
    Oh-ishi S; Satoh K; Hayashi I; Yamazaki K; Nakano T
    Thromb Res; 1982 Oct; 28(1):143-7. PubMed ID: 6925403
    [No Abstract]   [Full Text] [Related]  

  • 47. The effects of aprotinin on the phagocytic activity of the reticuloendothelial system and plasma prekallikrein levels during endotoxin shock.
    Ogata H; Kim S; Fukazawa T; Midorikawa Y; Yamashiro C
    Prog Clin Biol Res; 1983; 111():309-22. PubMed ID: 6191338
    [No Abstract]   [Full Text] [Related]  

  • 48. Kinin activation as a predictive assay for adverse reactions to radiographic contrast medium.
    Carr DH; Walker AC
    Acta Radiol Diagn (Stockh); 1984; 25(4):337-42. PubMed ID: 6567445
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chromogenic substrate assays for studying components of the plasma kallikrein system in health and disease.
    Gallimore MJ
    Adv Exp Med Biol; 1983; 156():225-31. PubMed ID: 6552839
    [No Abstract]   [Full Text] [Related]  

  • 50. [Effect of low-sodium diet and some hypotensive drugs on plasma levels of kininogen and prekallikrein in patients with arterial hypertension].
    Kolber-Postepska B; Kleinrok Z
    Pol Tyg Lek; 1976 Dec; 31(49):2085-8. PubMed ID: 1005186
    [No Abstract]   [Full Text] [Related]  

  • 51. Chromogenic peptide substrates. Their use for the assay of factors in the fibrinolytic and the plasma kallikrein-kinin systems.
    Friberger P
    Scand J Clin Lab Invest Suppl; 1982; 162():1-298. PubMed ID: 6221396
    [No Abstract]   [Full Text] [Related]  

  • 52. Factor XII assay with the chromogenic substrate chromozym PK.
    Dick W; Cullmann W; Müller N; Adler K
    J Clin Chem Clin Biochem; 1981 Jun; 19(6):357-61. PubMed ID: 6168728
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mechanized assay of plasma prekallikrein by activation with Pseudomonas aeruginosa elastase and amidolysis of chromogenic substrate.
    Shibuya Y; Yamamoto T; Tanaka H; Semba U; Kambara T; Okabe H
    Clin Chim Acta; 1991 Aug; 200(2-3):119-27. PubMed ID: 1777962
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Determination of prekallikrein in human plasma by kaolin adsorption method (author's transl)].
    Niwano A; Ikeda K; Yamada T; Naka H; Kiyose H; Hiraku S; Tamura S; Kira H; Hirata F
    Rinsho Byori; 1982 Mar; 30(3):315-9. PubMed ID: 6921272
    [No Abstract]   [Full Text] [Related]  

  • 55. Plasma prekallikrein and endotoxemia in liver cirrhosis.
    van Vliet AC; van Vliet HH; Dzoljić-Danilović G; Wilson JH
    Thromb Haemost; 1981 Feb; 45(1):65-7. PubMed ID: 7018004
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A novel chromogenic peptide for prekallikrein/kallikrein determination.
    Huang WY; Wan X; Zhang S
    Clin Lab; 2009; 55(3-4):106-13. PubMed ID: 19462932
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Plasma activity of contact coagulation factors in patients with IgA nephritis.
    Tan CC; Lee GS; Lee EJ; Woo KT
    Ann Acad Med Singap; 1996 Mar; 25(2):218-21. PubMed ID: 8799009
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prekallikrein deficiency in a dog.
    Chinn DR; Dodds WJ; Selcer BA
    J Am Vet Med Assoc; 1986 Jan; 188(1):69-71. PubMed ID: 3632973
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Effect of clonidine on various components of the plasma kinin system in patients with arterial hypertension].
    Kolber-Postepska B; Zebrowska-Lupina I; Markiewicz M; Kleinrok Z
    Pol Tyg Lek; 1984 Apr; 39(15):505-8. PubMed ID: 6567195
    [No Abstract]   [Full Text] [Related]  

  • 60. [Isolation and determination of human plasma prekallikrein].
    Simonianová E; Rybák M; Kasafírek E; Lostický C
    Cesk Farm; 1984 Dec; 33(10):417-9. PubMed ID: 6570444
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.